In patients carrying two expanded alleles (96%) in FRDA patients, the length of the allele with the shorter GAA expansion inversely correlates with frataxin levels, age of onset, and rate of disease progression; longer alleles result in earlier onset and faster progression [15–18]. The gene discussed is FXN; the disease is Friedreich ataxia.